Consult the FDA and a licensed healthcare professional for current regulations and individualized guidance.
Your plan should specify when to move up, when to hold, and what to do after a missed dose
A minimum number of 100 surveys total and at least 30 surveys for each channel are required to be included
Nieman, M
Stop and Seek Help If Any signs of allergic reactionhives, swelling, breathing difficulty (stop immediately, seek help) Severe or persistent headaches that don't respond to dose reduction Excessive daytime drowsiness affecting your ability to function Unusual mood changes or psychological symptoms You've completed your planned cycle (typically 4-6 weeks) Your healthcare provider recommends discontinuation DSIP is a research peptide, not an FDA-approved medication
Unknown Pharmacokinetics We dont fully understand how these medications behave in the body at micro-doses, including their absorption, distribution, and elimination patterns